医学
急性胰腺炎
胰腺炎
糖尿病
危险分层
内科学
重症监护医学
胰岛素
急诊医学
胰腺切除术
曲线下面积
疾病严重程度
诊断代码
住院
儿科
医疗保健系统
编码(社会科学)
胰岛素依赖型糖尿病
作者
Ishanu Chattopadhyay,Dmytro Onishchenko,Philip Kern,Darwin Conwell
出处
期刊:Pancreas
[Lippincott Williams & Wilkins]
日期:2026-07-01
标识
DOI:10.1097/mpa.0000000000002697
摘要
OBJECTIVES: Acute pancreatitis (AP) has heterogeneous trajectories: some patients deteriorate rapidly and require ICU care, whereas others develop delayed sequelae such as exocrine pancreatic dysfunction (EPD) and pancreatogenic diabetes. Existing scoring systems are burdensome, not available at first presentation, and poorly suited for forecasting longer-term outcomes. METHODS: Our AI platform operating exclusively on routinely collected EHR predict three outcomes after a first recorded AP diagnosis: (i) ICU admission (same-day, within 1 wk, within 2 wk), (ii) incident EPD, and (iii) incident insulin dependence among patients without prior diabetes diagnosis or anti-hyperglycemic prescriptions. Models were trained and validated using a U.S. administrative claims database comprising 164 million individuals. RESULTS: We demonstrate Area Under the Receiver-operating curve (AUC) of 0.986 (same-day ICU), 0.933 (ICU within 1 wk), and 0.927 (ICU within 2 wk). For longer-term outcomes, AUCs were 0.913 (male) and 0.901 (female) for incident EPD, and 0.861 (male) and 0.884 (female) for incident insulin dependence. Established chronic pancreatitis risk factors (e.g., obesity, tobacco dependence) are recovered with large effect sizes and high significance, supporting epidemiologic plausibility. Negative associations were consistent with etiologic subtypes, competing risks, and healthcare utilization patterns. CONCLUSIONS: Using only existing coded longitudinal history from a U.S. administrative claims environment,, ZeBRA enables simultaneous, test-free prediction of early deterioration and delayed pancreatic sequelae after AP, providing a scalable and interpretable basis for early risk stratification and targeted follow-up across the AP-chronic pancreatitis continuum. Broader clinical adoption will require external validation, especially in non-U.S. health systems and datasets with different coding and care-delivery structures.
科研通智能强力驱动
Strongly Powered by AbleSci AI